Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

34.34
Delayed Data
As of 12:06pm ET
 +0.41 / +1.21%
Today’s Change
30.89
Today|||52-Week Range
59.00
-40.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Operating ActivitiesNet Income / Starting Line1.2B1.4B1.5B1.5B
 
 
 
 
 
Depreciation148.3M92.3M108.1M110.6M
 
 
 
 
 
Total Other Cash Flow160.1M143.0M208.1M1.1B
 
 
 
 
 
Funds From Operations1.5B1.6B1.8B2.6B
 
 
 
 
 
Funds From/For Other Operating Expenses34.6M524.3M-357.5M359.8M
 
 
 
 
 
Net Cash Flow - Operating Activities1.5B1.1B2.2B2.3B
 
 
 
 
 
 
InvestingIncrease In Investments-223.1M-72.5M-6.9M-15.0M
 
 
 
 
 
Decrease In Investments-2.3M0.00301.8M4.3M
 
 
 
 
Capital Expenditures-321.1M-161.3M-253.4M-268.1M
 
 
 
 
 
Fixed Asset Disposal-862.2K0.00149.4K150.0K
 
 
 
 
Other Investing - Uses29.0M0.000.000.00
 
 
Net Cash Flow Investing-693.2M-241.2M31.0M-401.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-645.7M-555.3M-544.9M-541.0M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total12.3M-2.4B-25.0M-1.1B
 
 
 
 
 
Other Sources - Financing0.00415.7M-415.7M0.00
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-633.5M-2.5B-985.5M-1.7B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash2.7M-19.7M6.8M1.0M
 
 
 
 
 
 
Net Change In Cash143.5M-1.7B1.2B195.7M